• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 82 of 100
Hillary Clinton Holds Post-Super Tuesday Rally In NYC
Finance
This Is Why Hillary Clinton’s Attack on Drug Price Hikes Doesn’t Add Up
By Jen WiecznerMarch 4, 2016
97236087
Health
The FDA Wants to Find Out if Cartoon Drug Ads Are Bad for Consumers
By Sy MukherjeeMarch 2, 2016
The Newly Refurbished Charles Dickens Museum Prepares To Open
Health
Female Viagra Might Not Be All It’s Cracked Up To Be
By Robert HackettMarch 1, 2016
559537925
Health
Why Shares of Diplomat Pharma Got Slammed Today
By Sy MukherjeeMarch 1, 2016
Roche's colon-cancer drug Avastin is displayed in a Cambridg
Health
The US Throws Away $3 Billion Worth of Cancer Drugs A Year
By Laura LorenzettiMarch 1, 2016
Cancer research laboratory
Health
Pharma’s Big New Cancer Drug May Be an Old Red Dye
By ReutersFebruary 26, 2016
Exclusive Look At Pharmaceuticals Manufacturing Inside Lupin Ltd. Facility, India's Third-Largest Drugmaker
Finance
Indian Companies Want to Sell U.S. Customers More Drugs
By Laura LorenzettiFebruary 25, 2016
An Initiative To Legalize Marijuana In California To Appear On Nov. Ballot
Retail
Canada’s Biggest Drugstore Could Start Selling Medical Marijuana
By Tom Huddleston Jr.February 24, 2016
CVS - Most Admired 2016
Health
CVS Health Says Prescription Drug Spending Dropped Dramatically
By Laura LorenzettiFebruary 23, 2016
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
Finance
Here’s Why Valeant Shares Are Plunging Again
By ReutersFebruary 23, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
Finance
Here’s Why Shares of Valeant Have Plunged for Their Second Straight Day
By ReutersFebruary 22, 2016
Production At The Merck KGaA Pharmaceutical Plant
Health
China suspends Ali Health-run online drug monitoring platform
By ReutersFebruary 21, 2016
UNITED STATES - FEBRUARY 04: Martin Shkreli, former CEO Turing Pharmaceuticals, invoked his Fifth Amendment right against self-incrimination during a House Oversight and Government Reform Committee in Rayburn Building on "methods and reasoning behind recent drug price increases," February 04, 2016. Turing had raised the price of Daraprim, used by AIDS and cancer patients, from $13.50 to $750 a pill. (Photo By Tom Williams/CQ Roll Call)
Leadership
Several Witnesses in the Martin Shkreli Case Are Worried About Retaliation
By ReutersFebruary 19, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Health
These Philanthropists Just Gave $7.2 Million to Solve the Drug Price Crisis
By Laura LorenzettiFebruary 17, 2016
Daily Antiretroviral Pill Found To Protect Healthy From AIDS Transmission
Health
Express Scripts Won’t Air ‘Dirty Laundry’ In Heated Anthem Dispute
By Laura LorenzettiFebruary 17, 2016
1...
  • 80
  • 81
  • 82
  • 83
  • 84
...100
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Personal Finance
Current price of oil as of July 1, 2026placeholder alt text
By Joseph HostetlerJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.